Interviews

Peter Schneider, MD, discusses the IN.PACT SFA II trial, the US arm of a clinical study for the IN.PACT Admiral drug-eluting balloon (Medtronic) as a treatment for peripheral artery disease in the superficial femoral and proximal popliteal...

Robert J. Kennedy, MD, discusses the use of ultrasound-accelerated thrombolysis at the 2013 International Symposium on Endovascular Therapy meeting.

At the 2012 VEITHsymposium, Christopher Kwolek, MD, gave a presentation describing the use of the Vortex AngioVac Suction Cannula (AngioDynamics) for pulmonary emboli. Vascular Disease Management spoke with Dr. Kwolek about new developments...

Gary M. Ansel, MD, discusses the recent FDA approval of the Zilver PTX drug-eluting stent for the treatment of peripheral artery disease.

Dr. Eric Verhoeven spoke with Vascular Disease Management about considering the condition and lifestyle of each patient when choosing the right treatment for popliteal aneurysm.

Each year, the VEITHsymposium gets more complete and comprehensive. This symposium really provides an almost total overview of everything that’s new, different, and exciting in vascular disease management, certainly in vascular surgery and...

My patient was a 70-year-old gentleman with two issues that made him an excellent candidate to consider for aortic endografting. The first was that he had a hostile abdomen secondary to a previous Whipple procedure and multiple subsequent...

During pregnancy, the risk of blood clots in the legs or blood clots going to the lungs increases 4-5 fold. It is more frequently observed during the third trimester.

As a medical community, we decided that there were unmet needs both in the patient population and physician population for education and awareness of what venous disease is, how to prevent it, and how to treat it. We now have so much...

Dr. Sherif Sultan explores the latest treatments for aortic aneurysm at the Veith Symposium 2011. Read more at Vascular Disease Management.